Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine-dexmedetomidine for CPSP after Scoliosis Surgery
NCT05718544Phase 4Completed
- Sponsor
- Peking University First Hospital
- Start
- Jan 2023
- Primary completion
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of esketamine, dexmedetomidine in chronic postsurgical pain (CPSP), sponsored by Peking University First Hospital. Started Jan 2023; status: completed.
02
Drugs
esketaminedexmedetomidine
03
Conditions
chronic postsurgical pain (CPSP)
Beyond the preview
Go deeper on NCT05718544.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05718544.